Abnormal Alpha Granule Content C4022863
A blood platelet abnormality where platelet storage granules contain abnormal levels of proteins, potentially affecting blood clotting and increasing bleeding risk.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Spontaneous Bleeding
Unexpected bleeding from mucous membranes or internal sites without apparent cause.
Seek immediate medical care for any sudden, unexplained, or severe bleeding
Gastrointestinal Hemorrhage
Bleeding in the digestive tract that may appear as blood in stool or vomit.
Seek emergency care immediately if you notice black/tarry stool, bright red blood in stool, or vomiting blood
Petechiae
(dermatologic)Small red or purple spots on the skin caused by bleeding under the surface, typically appearing on legs or feet.
Frequency: 70-80% of patients
Easy Bruising
(dermatologic)Development of bruises (ecchymoses) with minimal trauma due to impaired platelet function.
Frequency: 75-85% of patients
Prolonged Bleeding Time
(hematologic)Extended time for bleeding to stop after a minor cut or injury due to defective platelet alpha granules.
Frequency: 60-70% of patients
Gingival Bleeding
(gastrointestinal)Bleeding from the gums, especially during brushing, flossing, or eating.
Frequency: 50-60% of patients
Epistaxis
(respiratory)Frequent or prolonged nosebleeds that may occur spontaneously or with minimal irritation.
Frequency: 45-55% of patients
Menorrhagia
(reproductive)Unusually heavy or prolonged menstrual bleeding in individuals assigned female at birth.
Frequency: 40-50% of patients
Fatigue
(constitutional)Persistent tiredness or weakness that may be related to chronic blood loss or anemia.
Frequency: 25-35% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Platelet Transfusion
Transfusion of donor platelets to temporarily replace dysfunctional alpha granules and improve clotting function in bleeding situations.
Desmopressin (DDAVP)
Synthetic hormone that stimulates release of von Willebrand factor and may improve platelet function by increasing Factor VIII levels.
Additional treatment options
Bleeding Precaution Measures
Avoidance of activities with high injury risk, use of protective gear, and modification of home environment to minimize trauma and bleeding episodes.
lifestyleRegular Hematology Follow-up
Scheduled monitoring of platelet function, bleeding time, and overall hematological parameters to track disease progression and treatment efficacy.
monitoringAntifibrinolytic Agents
Medications such as tranexamic acid that help stabilize clots by preventing their breakdown, particularly useful for mucosal bleeding.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Alpha Granule Content C4022863?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders. Haemophilia. 2006;12(Suppl 3):128-136.
Gresele P, Falcinelli E, Momi S. Inherited platelet disorders. Internal and Emergency Medicine. 2013;8(3):195-206.
British Committee for Standards in Haematology. Guidelines for the investigation and management of hereditary platelet disorders. British Journal of Haematology. 2018;183(3):358-376.
Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nature Genetics. 2011;43(8):735-737.
Kahr WH, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome and macrothrombocytopenia. Nature Genetics. 2011;43(8):738-740.
Braun A, Kunzelmann C, Kossel H, et al. The hereditary alpha-granule storage pool disorder (SPD) - Gray platelet syndrome. Platelets. 1995;6(4):239-245.
Hoffbrand AV, Pettit JE, Vyas P. Color Atlas of Clinical Hematology. 4th ed. Philadelphia: Mosby Elsevier; 2010.
International Society on Thrombosis and Haemostasis. Platelet Physiology Subcommittee consensus on inherited platelet disorders. Journal of Thrombosis and Haemostasis. 2015;13(3):492-501.
Mhawech P, Saleem A. Inherited giant platelet disorders. American Journal of Clinical Pathology. 2000;113(3):367-377.
ClinicalTrials.gov. Study of patients with storage pool disease and other platelet disorders. Identifier: NCT00533520.
Medication Comparisons
Compare medications used to treat Abnormal Alpha Granule Content C4022863. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy